![]() |
BLFS | Biolife Solutions Inc |
Electromedical & Electrotherapeutic Apparatus |
Book value per $ invested | $ 0.28 |
Leverage | 12.66% |
Market Cap | $ 1.3B |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -20.5m |
Margin | -24.66% |
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.